Overview

Evaluation of the Effect of Systemic Proteolytic Enzyme Therapy.

Status:
Recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
1. To compare the postoperative pain between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day. 2. To compare the postoperative swelling (edema) between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day. 3. To compare the degree of trismus between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day. 4. Measure patients' perceptions of changes in their quality of life in the postoperative period and compare it between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day.
Phase:
Phase 3
Details
Lead Sponsor:
University of Baghdad
Treatments:
Amoxicillin
Metronidazole